FMR CORP 13D and 13G filings for Repare Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-02-09 12:31 pm Sale |
2023-02-09 | 13G | Repare Therapeutics Inc. RPTX |
FMR CORP | 876,178 2.088% |
-2,145,135![]() (-71.00%) |
Filing |
2022-02-09 10:24 am Purchase |
2022-02-08 | 13G | Repare Therapeutics Inc. RPTX |
FMR CORP | 3,021,313 7.239% |
263,938![]() (+9.57%) |
Filing |
2021-02-08 10:31 am Purchase |
2021-02-05 | 13G | Repare Therapeutics Inc. RPTX |
FMR CORP | 2,757,375 7.499% |
2,757,375![]() (New Position) |
Filing |